TL;DR: CMS retired NCD 305 (section 220.6.7) for FDG PET in head and neck cancers, replacing it with section 220.6.17 — a change that took effect April 3, 2009, but was formally removed from the NCD Manual on April 10, 2023. If your billing team is still referencing NCD 305 for FDG PET head and neck claims, you're working from a dead policy document.

The Centers for Medicare & Medicaid Services updated NCD 305 on January 9, 2026, to reflect the formal retirement of section 220.6.7 governing FDG PET coverage for head and neck cancers. The operative guidance now lives entirely in section 220.6.17, which consolidated FDG PET coverage under the broader PET Scans NCD (§220.6). No specific CPT or HCPCS codes are listed in the retired policy document itself — all applicable code-level guidance is in §220.6.17.


Quick-Reference Table

Field Detail
Payer CMS
Policy FDG PET for Head and Neck Cancers (Replaced with Section 220.6.17) — RETIRED
Policy Code NCD 305
Change Type Modified (Retirement / Consolidation)
Effective Date April 10, 2023 (formal removal); January 9, 2026 (latest revision)
Impact Level Medium
Specialties Affected Oncology, Radiology, Nuclear Medicine, ENT/Head & Neck Surgery
Key Action Stop referencing NCD 305 / §220.6.7 for FDG PET head and neck claims — update all internal billing guidelines to point to §220.6.17

CMS FDG PET Head and Neck Cancer Coverage Criteria and Medical Necessity Requirements 2026

Here's the core issue: section 220.6.7 is gone. It has been gone since April 3, 2009. CMS formally pulled it from the NCD Manual on April 10, 2023. The January 9, 2026 update is the latest administrative revision confirming that retirement.

The CMS FDG PET head and neck cancer coverage policy now lives exclusively under section 220.6.17 of the NCD Manual. That section, part of the broader PET Scans NCD (§220.6), controls all coverage determinations, medical necessity criteria, and billing guidelines for FDG PET in head and neck cancer indications.

If your team has any internal documentation, charge capture templates, or prior authorization checklists that reference NCD 305 or §220.6.7 specifically, those references are stale. Using retired policy language in appeals or medical necessity documentation creates unnecessary exposure.

The real issue with a retirement like this is not the clinical change — FDG PET coverage for head and neck cancers didn't fundamentally disappear. The risk is administrative drift. Teams that built workflows around §220.6.7 and never updated them may be citing a retired section in documentation, appeals letters, or payer correspondence without realizing it.

For prior authorization purposes, §220.6.17 is the governing document. If a payer correspondent or MAC asks you to cite the applicable NCD, §220.6.7 is not the right answer. Point to §220.6.17 and the PET Scans NCD at §220.6.

Medical necessity determinations for FDG PET in head and neck cancer still require alignment with Medicare's coverage criteria — but you need to verify those criteria against §220.6.17, not the retired §220.6.7. The two sections may overlap significantly, but the retired section carries no weight in a coverage dispute.


Coverage Indications at a Glance

Because section 220.6.7 is retired and no longer contains active coverage criteria, the table below reflects the policy's current status. All active indication-level coverage guidance is in §220.6.17.

Indication Status Relevant Codes Notes
FDG PET for head and neck cancers (under §220.6.7) Retired / No longer operative None listed in retired NCD 305 All coverage criteria moved to §220.6.17 effective April 3, 2009
FDG PET for head and neck cancers (under §220.6.17) Active — see §220.6.17 See PET Scans NCD §220.6 This is the operative coverage policy — reference this section for all claims and appeals

This policy is now in effect (since 2026-03-12). Verify your claims match the updated criteria above.

CMS FDG PET Billing Guidelines and Action Items 2026

This is a housekeeping change with real operational teeth if your team hasn't caught it. Here's what to do now.

#Action Item
1

Audit your internal billing guidelines now. Search every policy document, charge capture template, and appeal letter template your team uses for any reference to "NCD 305," "§220.6.7," or "section 220.6.7." Replace those references with §220.6.17 and the active PET Scans NCD (§220.6).

2

Update your payer correspondence templates before your next FDG PET head and neck claim goes out. Any medical necessity letter or appeal that cites §220.6.7 cites a retired policy. That's a detail a payer's utilization management team can — and sometimes will — use against you.

3

Verify your MAC's local coverage determination guidance. The NCD sets the floor, but your Medicare Administrative Contractor may have issued additional guidance under §220.6.17. Check your MAC's website for any LCD or article that references FDG PET in head and neck cancers. Regional requirements can layer on top of the national coverage policy.

+ 3 more action items

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

If your organization does significant FDG PET billing for head and neck cancer patients and you're unsure how well your current workflow maps to §220.6.17, loop in your compliance officer or a billing consultant before your next audit cycle. A retired policy reference in medical necessity documentation is a minor issue until it shows up in a payer audit — then it becomes a bigger conversation.


Sample Version Diff Line-by-line changes
Previous VersionCurrent Version
Coverage is considered experimental and investigational for all indicationsCoverage is considered medically necessary when specific criteria are met
Prior authorization is not requiredPrior authorization is required for initial treatment
Documentation must include clinical historyDocumentation must include clinical history
+ 1 more action items

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

CPT, HCPCS, and ICD-10 Codes for FDG PET Head and Neck Cancers Under NCD 305

Covered CPT Codes

The retired NCD 305 policy document does not list specific CPT or HCPCS codes. CMS did not include code-level detail in the §220.6.7 retirement notice. All applicable CPT and HCPCS codes for FDG PET billing — including codes used for head and neck cancer indications — are governed by the active PET Scans NCD at §220.6 and section 220.6.17 specifically.

Code Type Description
Not specified in NCD 305 See §220.6.17 and the active PET Scans NCD (§220.6) for all applicable codes

A Note on Code Lookup for FDG PET Billing

This is not a case where the payer is removing codes from coverage. The codes themselves — whatever CPT codes your team uses for FDG PET in head and neck cancer — are addressed in the active policy at §220.6.17. The retirement of §220.6.7 was a policy consolidation, not a code-level coverage change.

Your revenue cycle team should pull the current code list directly from §220.6.17 and the CMS Medicare Coverage Database entry for the PET Scans NCD. Cross-reference that against your charge master to confirm your FDG PET head and neck codes are still correctly mapped to an active coverage policy and not orphaned to a retired NCD section.

If you're seeing claim denial rates increase on FDG PET head and neck cases, this administrative mismatch — citing a retired policy — is one of the first things to rule out. It's a solvable problem, but only if your team knows to look for it.


Get the Full Picture

Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.

🔍 Search by any code 🔔 Real-time alerts 📊 Line-by-line diffs ⏰ Deadline tracking
Get Full Access → $99/mo · 14-day money-back guarantee